RS2 Healthcare Partners (formerly Riverside Partners, Boston)
The Boston firm formerly known as Riverside Partners, rebranded in 2026 around its healthcare franchise. RS2 buys healthcare and healthcare technology companies with $3M to $15M of EBITDA: pharma services, device contract manufacturing, RCM, and provider services.
| Headquarters | Boston, Massachusetts |
|---|---|
| Fund size / AUM | Fund VI current; $1.6B raised since inception; Fund V $561M |
| Check size / target EBITDA | EBITDA $3M-$15M |
| Target company size | $5M-$15M EBITDA |
| Sector focus | Healthcare (pharma services, medical device contract manufacturing, tech-enabled healthcare, HCIT, RCM, provider services) + technology |
| Strategy | Buyout |
| Add-on acquisitions | Active add-on acquirer |
| Website | riversidepartners.com |
Compiled from RS2 Healthcare Partners (formerly Riverside Partners, Boston)'s website and public announcements. Numbers change as new funds close; treat this as a starting point, not a term sheet. Report a correction.
Selling to a firm like this?
Buyers like RS2 Healthcare Partners (formerly Riverside Partners, Boston) will test your numbers before they trust them.
Crawford McMillan gets mid-market companies diligence-ready: revenue you can trace, metrics you can defend, reporting that holds up in a data room. Free weekly brief on what buyers actually look for.
Get Inside the Data Room